(±)7(8)-EpDTE manufacturers
- (±)7(8)-EpDTE
-
- $323.00
-
2026-04-20
- CAS:1616607-36-3
- Purity:
- Supply Ability: 10g
|
| | (±)7(8)-EpDTE Basic information |
| Product Name: | (±)7(8)-EpDTE | | Synonyms: | (±)7(8)-EpDTE;2-Oxiranehexanoic acid, 3-(2Z,5Z,8Z,11Z)-2,5,8,11-tetradecatetraen-1-yl-;(±)7(8)-EpDTE;(±)7(8)-Epdote | | CAS: | 1616607-36-3 | | MF: | C22H34O3 | | MW: | 346.5 | | EINECS: | | | Product Categories: | | | Mol File: | 1616607-36-3.mol |  |
| | (±)7(8)-EpDTE Chemical Properties |
| Boiling point | 485.2±40.0 °C(Predicted) | | density | 0.982±0.06 g/cm3(Predicted) | | pka | 4.77±0.10(Predicted) |
| | (±)7(8)-EpDTE Usage And Synthesis |
| Description | (±)7(8)-EpDTE is an oxylipin and an oxidative metabolite of docosapentaenoic acid (DPA). It is formed via cytochrome P450 (CYP) metabolism of DPA, and can be further metabolized to (±)7(8)-DiHDTE by epoxide hydrolase. | | Uses | (±)7(8)-EpDTE is an oxylipin and an oxidative metabolite of docosapentaenoic acid[1]. | | References | [1] Yanai Ryoji, et al. Cytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization. Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9603-8. DOI:10.1073/pnas.1401191111 |
| | (±)7(8)-EpDTE Preparation Products And Raw materials |
|